{"id":"clobetasol-ointment","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin atrophy"},{"rate":null,"effect":"Striae"},{"rate":null,"effect":"Telangiectasia"},{"rate":null,"effect":"Folliculitis"},{"rate":null,"effect":"Hypertrichosis"},{"rate":null,"effect":"Acneiform eruptions"},{"rate":null,"effect":"Hypopigmentation"},{"rate":null,"effect":"Secondary infection"}]},"_chembl":{"chemblId":"CHEMBL1201362","moleculeType":"Small molecule","molecularWeight":"410.91"},"_dailymed":{"setId":"09717dc5-eef3-4f50-a346-f91d7e86fec9","title":"CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE OINTMENT USP, 0.05%) OINTMENT [BRYANT RANCH PREPACK]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Clobetasol propionate is a Class I (super-potent) corticosteroid that works by activating intracellular glucocorticoid receptors, leading to decreased production of inflammatory mediators, reduced immune cell infiltration, and suppression of local inflammatory responses. It reduces erythema, pruritus, and other signs of skin inflammation through these anti-inflammatory and immunosuppressive mechanisms.","oneSentence":"Clobetasol propionate is a potent topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:30:12.673Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses"},{"name":"Psoriasis"},{"name":"Eczema"},{"name":"Lichen planus"},{"name":"Vitiligo (adjunctive)"}]},"trialDetails":[{"nctId":"NCT03926299","phase":"NA","title":"Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus","status":"COMPLETED","sponsor":"Prof. Dr. Volker Viereck","startDate":"2019-07-15","conditions":"Chronic Skin Disease, Vulvar Lichen Sclerosus","enrollment":66},{"nctId":"NCT06504160","phase":"PHASE1","title":"Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-04-10","conditions":"Atopic Dermatitis","enrollment":86},{"nctId":"NCT07398807","phase":"EARLY_PHASE1","title":"Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited Vitiligo","status":"RECRUITING","sponsor":"Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan","startDate":"2025-08-08","conditions":"Vitiligo","enrollment":40},{"nctId":"NCT07240519","phase":"NA","title":"To Compare Inflammatory Biomarkers Before and After Treatment With Clobetasol or Fractional CO2 Laser, in Women With Histologically Confirmed Vulvar Lichen Sclerosus, Without Prior Corticosteroid Treatment.","status":"RECRUITING","sponsor":"Universidade Federal do Rio de Janeiro","startDate":"2022-06-22","conditions":"Vulvar Lichen Sclerosus","enrollment":40},{"nctId":"NCT06742333","phase":"PHASE2","title":"Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2025-07-22","conditions":"Psoriasis","enrollment":40},{"nctId":"NCT07240389","phase":"NA","title":"Treatment of Vulvar Lichen Sclerosus With Corticosteroid Ointment, Calcineurin Inhibitor Ointment, and Platelet-Rich Plasma (PRP) Therapy.","status":"NOT_YET_RECRUITING","sponsor":"Milosz Pietrus","startDate":"2025-12-01","conditions":"Vulvar Lichen Sclerosus","enrollment":45},{"nctId":"NCT04951206","phase":"PHASE4","title":"Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus","status":"COMPLETED","sponsor":"Medstar Health Research Institute","startDate":"2022-03-01","conditions":"Vulvar Lichen Sclerosus","enrollment":212},{"nctId":"NCT02392130","phase":"PHASE1","title":"A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-03","conditions":"Skin Tissue Diseases, Connective Tissue Diseases","enrollment":40},{"nctId":"NCT02355639","phase":"PHASE1","title":"A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-01","conditions":"Skin and Connective Tissue Diseases","enrollment":16},{"nctId":"NCT01043224","phase":"PHASE1","title":"A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-01","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT01946386","phase":"PHASE1","title":"A Vasoconstriction Study With LEO 90100","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2013-09","conditions":"Psoriasis Vulgaris","enrollment":35},{"nctId":"NCT06555497","phase":"EARLY_PHASE1","title":"Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With Psoriasis","status":"COMPLETED","sponsor":"Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium","startDate":"2022-01-01","conditions":"Pilot Study, Psoriasis","enrollment":2},{"nctId":"NCT00733954","phase":"PHASE4","title":"Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-08","conditions":"Plaque Psoriasis","enrollment":250},{"nctId":"NCT00658788","phase":"PHASE3","title":"Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-03","conditions":"Psoriasis","enrollment":305},{"nctId":"NCT00988637","phase":"PHASE4","title":"Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2009-10","conditions":"Plaque Psoriasis","enrollment":138},{"nctId":"NCT00437255","phase":"PHASE4","title":"Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-08","conditions":"Plaque Psoriasis","enrollment":122},{"nctId":"NCT05228483","phase":"NA","title":"Carbon Dioxide（CO2）Fractional Laser Plus Photodynamic Therapy in Female Patients With Vulvar Lichen Sclerosus","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2021-11-23","conditions":"Vulva Lichen Sclerosus","enrollment":134},{"nctId":"NCT02573883","phase":"PHASE3","title":"Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus","status":"COMPLETED","sponsor":"Medstar Health Research Institute","startDate":"2015-10","conditions":"Vulvar Lichen Sclerosus","enrollment":52},{"nctId":"NCT01282515","phase":"PHASE2, PHASE3","title":"Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDT","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2011-08","conditions":"Genital Lichen Planus","enrollment":40},{"nctId":"NCT04719559","phase":"NA","title":"Fractional Laser and Steroid Ointment to Improve the Old Scar After Thyroidectomy","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2018-03-20","conditions":"Thyroid; Wound, Steroid Acne","enrollment":10},{"nctId":"NCT04685031","phase":"PHASE1, PHASE2","title":"Ointment Therapy and Prevention of Cannulation-Induced Superficial Phlebitis","status":"UNKNOWN","sponsor":"Komar University of Science and Technology","startDate":"2021-02-01","conditions":"Phlebitis","enrollment":110},{"nctId":"NCT01591785","phase":"NA","title":"Treatment of Staphylococcus Aureus Colonization in Hand Eczema","status":"COMPLETED","sponsor":"Gary Goldenberg","startDate":"2012-01","conditions":"Hand Eczema, Foot Eczema","enrollment":60},{"nctId":"NCT03286582","phase":"PHASE2","title":"A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid","status":"TERMINATED","sponsor":"TWi Biotechnology, Inc.","startDate":"2017-09-05","conditions":"Bullous Pemphigoid","enrollment":10},{"nctId":"NCT02319616","phase":"PHASE1, PHASE2","title":"Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis","status":"WITHDRAWN","sponsor":"University of California, Davis","startDate":"2016-11","conditions":"Toxic Epidermal Necrolysis","enrollment":""},{"nctId":"NCT02680717","phase":"PHASE1","title":"Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea","status":"WITHDRAWN","sponsor":"Medical College of Wisconsin","startDate":"2016-03","conditions":"Scleroderma","enrollment":""},{"nctId":"NCT03399526","phase":"PHASE1","title":"1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-02-11","conditions":"Psoriasis","enrollment":24},{"nctId":"NCT02936492","phase":"PHASE1","title":"BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study","status":"TERMINATED","sponsor":"Bayer","startDate":"2016-10-24","conditions":"Psoriasis","enrollment":32},{"nctId":"NCT02416531","phase":"NA","title":"Vulvar Lichen Sclerosus: Comparison Between Clobetasol Propionate, Photodynamic Therapy and Low-Intensity Laser","status":"COMPLETED","sponsor":"Daniela de Fátima Teixeira da Silva","startDate":"2015-01","conditions":"Vulvar Lichen Sclerosus","enrollment":30},{"nctId":"NCT02973776","phase":"PHASE1","title":"Vasoconstriction Trial With LEO 90100 Aerosol Foam","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2016-12","conditions":"Psoriasis Vulgaris","enrollment":36},{"nctId":"NCT02940002","phase":"PHASE1","title":"BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-10-12","conditions":"Psoriasis","enrollment":23},{"nctId":"NCT02492373","phase":"NA","title":"Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation After QsNdYAG Laser","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2015-02","conditions":"Lentigines, Post Inflammatory Hyperpigmentation","enrollment":21},{"nctId":"NCT02733874","phase":"PHASE4","title":"A Trial That Compound Clobetasol Propionate Ointment Treats Patients With Mild to Moderate Psoriasis Vulgaris.","status":"COMPLETED","sponsor":"First Hospital of China Medical University","startDate":"2015-04","conditions":"Psoriasis","enrollment":240},{"nctId":"NCT02487212","phase":"PHASE4","title":"Treatment of Hypertrophic Scars Using Fractional Laser and Fractional Laser-assisted Topical Corticosteroid Delivery","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2014-04","conditions":"Hypertrophic Scars","enrollment":24},{"nctId":"NCT01012713","phase":"PHASE4","title":"Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2010-06","conditions":"Chronic Stable Plaque Psoriasis","enrollment":30},{"nctId":"NCT01703325","phase":"PHASE4","title":"Comparison of Efficacy of Intralesional Triamcinolone Injection and Clobetasol Propionate Ointment for Psoriatic Nails","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2010-11","conditions":"Psoriatic Nails","enrollment":16},{"nctId":"NCT01205880","phase":"PHASE4","title":"Study to Evaluate Vectical in Combination With Clobex Spray to Treatment Plaque Psoriasis","status":"COMPLETED","sponsor":"Emer, Jason, M.D.","startDate":"2009-12","conditions":"Psoriasis","enrollment":12},{"nctId":"NCT00779792","phase":"PHASE4","title":"Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation","status":"UNKNOWN","sponsor":"Odense University Hospital","startDate":"2008-09","conditions":"Dermatitis, Contact, Dermatitis, Occupational","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":57,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Clobex spray","Mucoadhesive Clobetasol Patch","Dermovate"],"phase":"marketed","status":"active","brandName":"Clobetasol Ointment","genericName":"Clobetasol Ointment","companyName":"National Institute of Allergy and Infectious Diseases (NIAID)","companyId":"national-institute-of-allergy-and-infectious-diseases-niaid","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Clobetasol propionate is a potent topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors. Used for Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Psoriasis, Eczema.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}